In recent years, in situ cancer vaccines, as an emerging cancer immunotherapy strategy,
have garnered considerable attention. This review comprehensively discusses the research …

The remarkable success of targeted immunotherapies is revolutionizing cancer treatment.
However, tumor heterogeneity and low immunogenicity, in addition to several tumor …

Conspectus Cancer vaccines have shown tremendous potential in preventing and treating
cancer by providing immunogenic antigens to initiate specific tumor immune responses. An …

Nanomaterial-based delivery vehicles such as lipid-based, polymer-based, inorganics-
based, and bio-inspired vehicles often carry distinct and attractive advantages in the …

Cancer nanovaccines represent a promising frontier in cancer immunotherapy, utilizing
nanotechnology to augment traditional vaccine efficacy. This review comprehensively …

Many advances have been made recently in the field of cancer immunotherapy, particularly
with the development of treatments such as immune checkpoint inhibitors and adoptive …

Cancer vaccines, which have been widely investigated in the past few decades, are one of
the most attractive strategies for cancer immunotherapy. Through the precise delivery of …

Cancer immunotherapy harnesses the immune system to attack tumors and has received
extensive attention in recent years. Cancer vaccines as an important branch of …

After 100 years of debate, it is clear that cancer is recognized by the immune system and this
has generated immense interest in cancer immunotherapy. The systemic nature of the …

Tumor vaccines aim to activate dormant or unresponsive tumor-specific T lymphocytes by
using tumor-specific or tumor-associated antigens, thus enhancing the body's natural …